111 results on '"Bianco, A.R."'
Search Results
2. The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: baseline endometrial sub-protocol data on the effectiveness of transvaginal ultrasonography and diagnostic hysteroscopy
3. Recombinant IFN-α2b treatment activates poly (ADPR) polymerase-1 (PARP-1) in KB cancer cells
4. The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol data
5. Preclinical and phase I study of oxaliplatin and topotecan in combination in human cancer
6. The ATAC ('Arimidex', tamoxifen, alone or in combination) adjuvant breast cancer trial: First results of the endometrial sub-protocol following 2 years of treatment.
7. Cytosine arabinoside increases the binding of 125I-labelled epidermal growth factor and 125I-transferrin and enhances the in
8. The ATAC (‘Arimidex’, Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment
9. Targeting c-erbB2 and Other Receptors of the C-ErbB Family: Rationale and Clinical Applications
10. Poly(ADP-ribose)polymerase (PARP-1) expression in malignant melanomas from photo exposed areas of the head and neck region
11. Epidermal growth factor receptor (EGFR) expression in cutaneous melanoma: A possible role as prognostic marker
12. 1086 Cetuximab in a randomized phase II trial as a single agent or in combination with irinotecan in patients with epidermal growth factor receptor (EGFR)-expressing, irinotecan-refractory metastatic colorectal cancer (CRC)
13. Second-Line Chemotherapy with a Hybrid-Alternating Regimen of Bolus 5FU Modulated by Methotrexate and Infusional 5FU Modulated by Folinic Acid in Patients with Metastatic Colorectal Cancer Pretreated with 5FU
14. Vinorelbine + Mitomycin C as Second-Line Treatment of Metastatic Breast Cancer: A Two-Stage Phase 2 Study
15. Oral administration of chimeric MBO antisense-protein kinase A inhibits growth, angiogenesis and growth factors production and cooperates with cytotoxic drugs in human cancer xenografts
16. Antiangiogenic and antitumor effect of VEGF antisense oligonucleotide in combination with anti-EGFR C225 monoclonal antibody in human colon cancer
17. A structured algorithm to assess the response to biological therapy in medullary thyroid carcinoma
18. P46 15 year update of the naples GUN trial of adjuvant breast cancer therapy: Evidence of interaction between c-erb-B2 expression and Tamoxifen efficacy
19. Mutations in the BRCA1 gene in it alian breast and ovarian cancer patients
20. Carboplatin plus vinorelbine: A new active regimen in extensive small cell lung cancer. Results of a multicenter phase II study
21. 213 Phase II study of vinorelbine in elderly patients with stage IIIB-IV non small cell lung cancer
22. 212 Carboplatin plus vinorelbine: A new active regimen in extensive small cell lung cancer. Results of a multicenter phase II study
23. Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study
24. Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial
25. High-dose recombinant interleukin-2/verapamil combination in advanced cancer
26. Selecting high-risk early breast cancer patients: What to add to the number of metastatic nodes?
27. First-line systemic therapy for metastatic breast cancer and management of pleural effusion
28. 45 ErbB2 overexpression affects tamoxifen efficacy in the adjuvant treatment of node negative operable breast cancer patients
29. Postmastectomy follow-up in patients with early breast cancer: Consensus or controversy?
30. α-Interferon Induces Depletion of Intracellular Iron Content and Up Regulation of Functional Transferrin Receptors on Human Epidermoid Cancer kb Cells
31. 5-Aza-2′-deoxycytidine induces growth inhibition and upregulation of epidermal growth factor receptor on human epithelial cancer cells
32. Phase I study of carboplatin, epirubicin and VP-16 plus G-CSF in extensive small cell lung cancer (SCLC)
33. Low-dose dopamine induces early recovery of recombinant interleukin-2—Impaired renal function
34. Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant surgery” for limited small cell lung cancer (SCLC)
35. High dose chemotherapy with epirubicin (E) and cyclophosphamide (C) plus hemopoietic colony stimulating factors in locally advanced (LABC) or metastatic (MBC) breast cancer. A phase I–II trial
36. Ondansetron in the prophylaxis of nausea and vomiting induced by carboplatin combination chemotherapy
37. Elevated serum levels of circulating intercellular adhesion molecule I in patients with liver disease treated with thymostimulin
38. Thynostimulin is effective treatment in hepatocellular carcinoma associated with liver cirrhosis
39. Cell Kinetics and Tumor-Associated Antigen Expression in Human Mammary Carcinomas
40. Second-Line Chemotherapy of Advanced Colorectal Cancer with Sequential High-Dose Methotrexate and 5-Fluorouracil
41. Impact of Preoperative CA 15-3 Levels in Operable Breast Cancer. Comparison with Tissue Polypeptide Antigen (TPA) and Carcinoembryonic Antigen (CEA)
42. Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant” surgery for limited small cell lung cancer (SCLC)
43. Clinical studies with B72.3 in ovarian cancer and probe-guided tumor localization
44. Changing presentation in non-Hodgkin lymphoma
45. CA 15-3 in Human Breast Cancer.: Comparison with Tissue Polypeptide Antigen (TPA) and Carcinoembryonic Antigen (CEA)
46. Clinical Trial with 5-Fluorouracil and Leucovorin
47. The Source of Ascitic Fluid in Experimental Cirrhosis in the Rat.
48. Polyamine Uptake by Human Colon Carcinoma Cell Line CaCo-2.
49. Studies of Some Immunological Properties of Thyroid Iodoproteins.
50. DOCETAXEL, VINORELBINE AND ZOLEDRONIC ACID AS FIRST LINE TREATMENT IN PATIENTS WITH HORMONE-REFRACTORY PROSTATE CANCER
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.